Hereditary Angioedema Market to Witness Robust Growth as BioCryst Pharmaceuticals, Inc. Receives the U.S. FDA Approval for its ORLADEYO indicated for hereditary angioedema

 

Hereditary Angioedema is a disease, which is the result of genetic mutation, within the families with higher genetic activity. It is not contagious to others. The cause of heredity is still unknown but it is believed that the disease is related to the immunological mechanism. Hereditary Angioedema is a chronic non-inflammatory disease that affects millions of people around the world. Symptoms include persistent dryness of the skin, scalp itching, inflammation, rash, severe skin peeling and cracking, bleeding and hives, pain in the area where the skin is affected. As a part of the diagnosis, a medical practitioner who is experienced in treating hereditary angioedema must do a skin biopsy to find out the exact cause of allergic skin reaction.

Rising awareness regarding hereditary angioedema is expected to drive growth of the global hereditary angioedema market during the forecast period. Hereditary angioedema or also referred to as HAE has received significant attention in the recent past as government and non-government organizations across the globe are focused on increasing public awareness to improve diagnosis and enhance the treatment. For instance, in April 2019, HAE International (HAEi) organized an HAE global walk across various countries including Argentina, Australia, New Zealand, Denmark, Finland, Malta, etc. Thus, these factors are expected to drive growth of the global hereditary angioedema market during the forecast period. Moreover, the prevalence of hereditary angioedema is expected to boost the global hereditary angioedema market growth over the forecast period. According to the National Institutes of Health (NIH), hereditary angioedema is expected to affect 1 in 500,000 people in the U.S., of which 85% of cases are expected to be Type I.

However, misdiagnosis of hereditary angioedema is expected to hamper the global hereditary angioedema market growth over the forecast period. Besides, continuous research and development activities in the field of orphan drug development can present lucrative growth opportunities in the global hereditary angioedema market in the near future. Among regions, North America is expected to witness significant growth in the global hereditary angioedema market during the forecast period. This is owing to the presence of robust healthcare infrastructure and new product launches by market players across the region. Moreover, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to rising patient awareness across the region.

Major companies involved in the global hereditary angioedema market are BioCryst Pharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., Pharming Group N.V., Attune Pharmaceuticals, Inc., CSL Limited, and Shire plc.

For instance, in December 2020, BioCryst Pharmaceuticals, Inc. received the U.S. Food and Drug Administration (FDA) approval for oral once-daily ORLADEYO for prophylaxis to prevent hereditary angioedema (HAE).

Increasing Prevalence of Chronic Disorders and Initiatives to Develop Flying Ambulance for Medical Emergency Use to Augment Growth of Air Ambulance Services Market

 Increasing prevalence of chronic disorders is expected to propel growth of the global air ambulance services market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Emergence of Covid-19 is expected to propel growth of the global air ambulance services market. For instance, globally, as of 6:51pm CET, 3 January 2021, there have been 83,322,449 confirmed cases of COVID-19, including 1,831,412 deaths, reported to the World Health Organization.

High cost of air ambulance services and the relative low adoption of these services in emerging economies compared to developed countries is expected to hinder growth of the global air ambulance services market.

Among regions, North America is expected to witness significant growth in the global air ambulance services market, owing to launch of new services. For instance, in September 2020, WellSpan Health, an integrated health system in the U.S., and Air Methods, a leading air medical service in the U.S., jointly launched a new medical helicopter service to improve access to emergency air transport services for the most critically injured or sick patients.

Asia Pacific is also expected to witness significant growth in the global air ambulance services market, owing to increasing initiatives to develop a flying ambulance for medical emergency use. For instance, in August 2020, EHang Holdings Limited, an autonomous aerial vehicle technology platform company, announced that it has been selected to join Ambular, an international project endeavoring to develop a flying ambulance for medical emergency use.

Competitive Analysis

Major players operating in the global air ambulance services market include, Air Methods Corporation, Deccan Charters, Scandinavian Air Ambulance, Air Ambulance Specialists, Air Charter Service, Envision Healthcare Companies, Falck Danmark A/S, AMR Air Ambulance, AirMed International, Air Methods, and Express Aviation Services.

Major players operating in the global air ambulance services market are focused on adopting partnership strategies to enhance their market share. For instance, in August 2020, Air Methods partnered with Borrego Health, a Federally Qualified Health Center in the U.S., to start a new Mercy Air base at the Borrego Medical Clinic in Borrego Springs, California, U.S.

Growing aging population along with the increasing prevalence of osteoarthritis and rheumatoid arthritis is propelling market growth of walking assist devices

 The main driving forces propelling the demand for walking assist devices are the surging demand for therapeutic rehabilitation equipment, the ever-increasing incidences of arthritis and rheumatism, and the steadily increasing aging population. In fact, as people grow older, many of them may be facing difficulties in walking long distances without feeling the pain. This can lead to serious problems such as loss of mobility, walking accidents, or even the inability to carry out their day to day activities.

The increasing aging population is a key factor fueling the market growth of the walking assist device. According to the United Nation, in 2019, there were 703 million persons aged 65 years or over in the global population. This number is projected to double to 1.5 billion in 2050. The rise in road accidents is again expected to augment the market growth of the walking assist device. Around 1.35 million people die each year as a result of road traffic crashes. 93% of the world's fatalities on the roads occur in low- and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Moreover, advancement in the walking assist device is further projected to foster market growth over the forecast period.

North America is expected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population in the region. According to the U.S. Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 Census and more than 54 million on July 1, 2019. Moreover, the high prevalence of osteoarthritis and rheumatoid arthritis in the region is further projected to foster the regional market growth over the forecast period. According to the Centers for Disease Control and Prevention, with the aging of the US population, the prevalence of doctor-diagnosed arthritis is expected to increase in the coming decades. By the year 2040, an estimated 78.4 million (25.9% of the projected total adult population) adults aged 18 years and older will have doctor-diagnosed arthritis

Key Developments:

In January 2019, Honda has announced that it has received Premarket Notification from the U.S. Food and Drug Administration (FDA) for its Walking Assist Device, developed to support people with reduced walking abilities.
In September 2017, Honda Australia launches it's first-ever brand TVC celebrating Honda’s innovative, human-centric philosophy to help stroke victims walk again.
In February 2019, Honda R&D Americas, Inc. announced that they and The Ohio State University have been awarded a grant by The Michael J. Fox Foundation (MJFF) to research the safety and potential positive impact that Honda's Walking Assist Device could have in helping people with Parkinson's disease (PD).

High Fructose Corn Syrup Market is Gaining Excellent Traction as Major Market Player Ingredion Inc. acquires 75% stake in PureCircle Ltd.’s stevia company

 High fructose corn syrup is often called cane sugar, corn sweetener, glucose syrup, or cane sugar, and is a sweetening agent made with corn starch. Unlike regular sugar, high fructose corn syrup is broken into sugar before being absorbed by the body. As in the production of ordinary corn syrup, the sugar is broken down to glucose by digestive enzymes. This simple process provides glucose to cells in the body that need it. However, due to the lack of calories and other nutrients in regular sugar, this type of sugar is not as readily absorbed as other sugar types.

Rising demand for sweeteners in the food and beverage industry is expected to drive growth of the global high fructose corn syrup market during the forecast period. In the food and beverage industry, high fructose corn syrup is mainly used as a sweetener, typically in cereal products, dairy, baking, canning, condiments, ice-creams, carbonated soft drinks, and confections & desserts. Generally, HFCS has been compared to granulated sugar as a sweetener. However, HFCS is easier to handle and more cost-effective. Furthermore, HFCS 55 is usually used in the production of soft drinks while HFCS is used in breakfast cereals and processed foods. The demand for confectionery and processed food is increasing rapidly in both developed and emerging economies, which in turn, is boosting the consumption of high fructose corn syrup. Thus, these factors are expected to drive growth of the global high fructose corn syrup market during the forecast period. Moreover, easy logistics and handling of HFCS are expected to boost the global high fructose corn syrup market growth over the forecast period.

However, rising concerns over diet intake combined with reduced intake of sweetened products globally and rising adoption of zero-calorie substitutes are expected to hamper the global high fructose corn syrup market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global high fructose corn syrup market during the forecast period High Fructose Corn Syrup. This is owing to rising production of HFCS in the region. According to the U.S. Department of Agriculture, the U.S. exported over 1.24 million metric ton of HFCS in 2017, increasing from 1.121 million metric ton in 2016.

Key players involved in the global high fructose corn syrup market are Cargill Inc., COFCO International, Tate & Lyle, Kerry Group Plc, Archer Daniels Midland Company, Japan Corn Starch Co., Ingredion Incorporated, and Global Sweeteners Holdings Limited.

For instance, in April 2020, Ingredion Inc., a U.S.-based manufacturer of high fructose corn syrup, acquired a 75% stake in PureCircle Ltd.’s stevia company.

Read More @ https://www.openpr.com/news/2017162/high-fructose-corn-syrup-market-growth-trends-highlighted-until

Pompe Disease Therapeutic Market to Grow Significantly as Key Marketer Sanofi announces clinically meaningful improvements for its Phase III trial of Enzyme Replacement Therapy

 Pompe disease or also referred to as Glycogen storage disease type II is an autosomal recessive metabolic disorder that damages nerve cells and muscles throughout the body. It is typically caused due to the accumulation of glycogen in the lysosome, owing to deficiency of the lysosomal acid alpha-glucosidase enzyme.

Rising prevalence of Pompe disease is expected to drive growth of the global Pompe disease therapeutic market during the forecast period. According to the National Organization for Rare Disorders (NORD), around 1 in 40,000 births in the U.S. and the Netherlands are affected with Pompe disease. According to the same source, a recent study showed that the state of Missouri reported a higher prevalence of 1 in 5,463. Pompe disease can occur in various populations and ethnic groups across the globe. According to the Pompe Disease News, around 5,000 to 10,000 people have Pompe diseases worldwide. As a result of this, the demand for new therapeutic treatment options is increasing globally. Thus, these factors are expected to drive growth of the global Pompe disease therapeutic market during the forecast period. Furthermore, proactive initiatives taken by government authorities to develop and manufacture innovative products for the diagnosis and treatment of rare diseases are expected to propel the global Pompe disease therapeutic market growth over the forecast period.

However, the high cost associated with treatment is expected to hinder the global Pompe disease therapeutic market growth over the forecast period. Continuous research and development activities can present lucrative growth opportunities in the global Pompe disease therapeutic market in the near future. Among regions, North America is expected to witness significant growth in the global Pompe disease therapeutic market during the forecast period. This is owing to the presence of robust healthcare infrastructure across the region. Furthermore, Europe is expected to register a robust growth rate over the forecast period, owing to continuous research and development activities combined with proactive support from government authorities to improve the healthcare sector.

Key companies operating in the global Pompe disease therapeutic market are CENTOGENE AG, Amicus Therapeutics, Inc., AVROBIO, Inc., Sanofi, Valerion Therapeutics, Audentes Therapeutics, and Oxyrane.

For instance, in June 2020, Sanofi announced results of Phase III trial for its investigational enzyme replacement therapy (ERT) avalglucosidase alfa indicated for late-onset Pompe disease (LOPD) with clinically meaningful improvement.

Read More @ https://prnewsleader.com/news/1785112/pompe-disease-therapeutic-market-by-commercial-sector-analysis-and-outlook-to-2027/

High potency active pharmaceutical ingredients are fast-acting drug that has improved effectiveness of treatment

 

High potency active pharmaceutical ingredients are molecules widely used in the production of hormonal drugs which are used for the treatment of breast cancer. It is also used in the central nervous system drugs, cardiovascular drugs, and musculoskeletal drugs. Moreover, recently they have been also gaining demand in the gynecology & cosmetics industry. These drugs are segmented into innovative and generic.

The growing prevalence of cancer is predominantly fueling the market growth of the high potency active pharmaceutical ingredients. The increasing number of the pharmaceutical industry coupled with the growing investment in the research and development activities conducted by the pharmaceutical industry is again contributing to the market growth. Moreover, increasing use of high potency active pharmaceutical ingredients as antibody-drug conjugates as it is one of the most important and effective treatments for cancer is also projected to augment the market growth. It is also used to treat glaucoma which is further anticipated to foster the market growth of the high potency active pharmaceutical ingredients.

From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of the chronic disease in the region. According to the National Health Council, chronic diseases affect around 133 million Americans, representing more than 40% of the total population of this country. About half of all adults have a chronic condition, and approximately 8 percent of children ages 5 to 17 were reported by their parents to have limited activities due to at least one chronic disease or disability.

Key Developments:

In September 2020, Seqens, a worldwide manufacturer of pharmaceutical ingredients, has launched a specialized production unit at its site in Villeneuve-La-Garenne, France. The $ 35 million (€ 30 million) facility will tackle the development and production of high potency active pharmaceutical ingredients (HPAPI).
In February 2020, Sanofi announced its plans to create a major European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), which are the essential molecules responsible for the beneficial effects used in the composition of any drug.
In June 2019, Lonza has invested in two multi-purpose production lines for HPAPI manufacturing at its Visp site in Switzerland. Lonza has also optimised capacity to improve its flexibility in existing production lines, supporting shorter time-to-market and accelerated approval timelines for partners.

Read More @ https://prnewsleader.com/tag/high-potency-active-pharmaceutical-ingredients-market-trend/

Fluctuations in Feedstock Prices to Boost Growth of the Petroleum Segment in the Absorption Chillers Market

 Absorption refrigerant chillers are refrigerant chillers that use an electromagnetic heating source to give the desired energy needed for the cooling process. The electromagnetic heating source used in an absorption refrigerant chillers is a low temperature refrigerant, typically water, that can be pumped or drawn into a reservoir where it becomes heated to a specific temperature. The temperature in the reservoir is then changed so that it can absorb the required heat and release the energy needed in the cooling process without causing the condenser coils to cool down too much.

Absorption chiller technology is used in commercial and industrial–and even food-processing and marine applications. In the IT sector, this technology is used in green focused data center facilities. Emergence of Covid-19 has led to increasing demand for data centers, thereby boosting growth of the global absorption chillers market.

Market Dynamics

Increasing development in data center infrastructure is expected to propel growth of the global absorption chillers market. For instance, in July 2020, Delta, a provider of power and thermal management solutions, launched SmartNode data center infrastructure solution to provide flexible power system and cooling designs for quick deployment of versatile implementation in Europe, the Middle East and Africa.

Moreover, increasing preference for absorption chillers over electric motor-driven compression cycle chillers is also expected to aid in growth of the global absorption chillers market. Absorption chillers use very little electricity compared to an electric motor-driven compression cycle chiller.

Among end users, the petroleum sector is expected to witness significant growth in the absorption chillers market, owing to fluctuations in feedstock prices. Earlier, low cost of fuel and feedstock made use of mechanical chillers affordable in the petrochemical industry. However, now the feedstock prices increasing, which has created lucrative growth opportunities for players in the absorption chillers market.

In the food and beverages sector, the adoption of absorption chillers has significantly increased as breweries are open to using absorption chillers to reduce their energy footprint.

Competitive Analysis

Major players operating in the global absorption chillers market include, Broad Air Conditioning Co. Ltd., Thermax Inc., Carrier Corporation, Shuangliang Eco-Energy Systems Co. Ltd., Kawasaki Thermal Engineering Co., Ltd., Hyundai Climate Control Co., Ltd., Johnson Controls, Inc., Robur Corporation, Yazaki Corporation, EAW Energieanlagenbau GmbH, and Trane Inc.

January 2019: Broad Air Conditioning Co. Ltd. developed a triple-effect absorption chiller that can produce chilled water down to 5 degree Celsius.

Read more @ https://prnewsleader.com/uncategorized/351829/absorption-chiller-market-down-to-a-trickle-month-other-covid-19-traders-cling-on-the-hope/

Increasing Adoption of Smartphones and Growing Geriatric Population to Augment Growth of E-Pharmacy Market

 

E-pharmacy as we know it today, provides pharmacy services to its customers through the use of the Internet. This technology has been around for quite some time but it wasn't until sometime ago that it started to gain popularity and slowly started replacing the traditional pharmacy. One of the advantages of using e-pharmacy over the traditional type of pharmacy is that there is no face to face interaction required between the customer and the pharmacists.

Market Dynamics

Increasing adoption of smartphones is expected to propel growth of the e-pharmacy market. For instance, according to Pew Research Center, 76% of adults in the U.K. owned a smartphone in 2018.

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the e-pharmacy market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. Moreover, increasing investment in e-pharmacy is also expected to aid in growth of the market. For instance, in November 2020, Alodokter, an Indonesian telemedicine app, raised an undisclosed amount of funding from MDI Ventures, the corporate VC arm of Telkom Indonesia, in order to launch e-pharmacy.

Emergence of Covid-19 has had a mixed response on the-pharmacy market. The COVID-19 pandemic has shifted preference to ATM pharmacies as majority of countries are under lockdown. The pandemic has also affected the revenue of several market players.

Among regions, Asia Pacific is expected to witness significant growth in the e-pharmacy market, owing to growing e-commerce sector in the region. For instance, according to India Brand Equity Foundation, the e-commerce sector in India is expected to reach US$ 200 billion by 2026 from US$ 38.5 billion as of 2017. Moreover, entry of new market players is also expected to aid in growth of the market in Asia Pacific. For instance, in November 2020, Amazon Inc. launched a pharmacy service in the South Indian city of Bengaluru.

Competitive Analysis

Major players operating in the global e-pharmacy market include, CVS Caremark, Banner Health, DocMorris NV, Ro, Zur Rose Group AG, Right ePharmacy, PlanetRx.com.Inc., Lloyds Pharmacy Ltd., Dr. Fox Pharmacy, eDrugstore.MD, MediSave, SastaSundar, Walgreen Co, and Rowlands Pharmacy.

Major players operating in the global e-pharmacy market are focused on adopting expansion strategies to enhance their market share. For instance, in December 2020, India-based e-pharmacy, SastaSundar, announced its plans to expand into the northern and western regions of India while strengthening its presence in the existing markets in the eastern and north-eastern regions.

Read more @ https://www.openpr.com/news/1919201/e-pharmacy-market-growth-includes-top-players-the-kroger-co

Increasing Adoption of Companion Animals and Increasing Expenditure on Animal Healthcare to Augment Growth of Animal Parasiticides Market

 Increasing adoption of companion animals is expected to propel growth of the animal parasiticides market. For instance, according to 2017-2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), the number of rabbits per 1,000 households in the U.S increased from 1,408 in 2012 to 1, 534 in 2017-2018. Moreover, increasing production of chicken is also expected to aid in growth of the market. For instance, in the Philippines, the production of dressed chicken increased 40% during 2009-2018, as per the Philippine Statistics Authority.

Increasing expenditure on animal healthcare is expected to offer lucrative growth opportunities for players in the animal parasiticides market. For instance, according to 2017-2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), the veterinary expenditure per animal in the U.S. was US$ 227 in 2012, which increased to US$ 253 in 2017-2018. Moreover, increasing outbreak of strains of Salmonella is also expected to aid in growth of the market. For instance, according to the Centers for Disease Control and Prevention, in 2019, 1,134 people infected with the outbreak strains of Salmonella were reported from 49 states and the District of Columbia in the U.S. The disease was caused due to people coming in contact with backyard poultry.

Increasing demand for vegan food is expected to hinder growth of the animal parasiticides market. For instance, according to The Vegan Society, the number of people consuming only vegetarian food in the U.K. increased from 276,000 in 2016 to 600,000 in 2019.

Among regions, North America is expected to witness significant growth in the animal parasiticides market, owing to increasing consumption of meat in the U.S. For instance, according to research presented at the 2018 Chicken Marketing Summit, Florida, U.S., 86% of consumers during a two week survey in the U.S. ate a chicken meal or snack purchased from a supermarket and 68% ate a chicken meal or snack from a food service establishment.

Competitive Analysis

Major players operating in the animal parasiticides market include, Merial (Boehringer Ingelheim GmbH), Ceva Sante Animlae, Virbac SA, Vetoquinol S.A., Eli Lilly and Company, Zoetis Inc., Merck & Co Inc., Bayer AG, and Perrigo Co. plc.

Major players operating in the animal parasiticides market are focused on adopting M&A strategies to expand their product portfolio. For instance, in August 2020, Merck Animal Health, a division of Merck & Co., Inc., acquired the worldwide rights to VECOXAN (diclazuril), an oral suspension for the prevention of coccidiosis in calves and lambs, from Elanco Animal Health.

Promising fertility rate is escalating demand for Preimplantation Genetic Diagnosis

 

Preimplantation Genetic Diagnosis is offering to help those that aren't sure if they can have children of their own or if they will suffer from certain medical issues in the future. Pregnancy and Fertility are two other reasons why this test can be offered. The procedure is done when the couple is preparing for conception by checking for any irregularities on an ultrasound. The genetic information from the unaffected parents and the affected eggs are compared to determine if a genetic problem exists with the egg of one of the partners.

The growing number of fertility clinics around the globe coupled with the advancement in the field of genetic analysis is driving the market growth of preimplantation genetic testing. The increasing need for early detection of chromosomal abnormalities in the fetus is another major factor fueling the market growth of preimplantation genetic testing. The advent of next-generation sequencing (NGS) is also contributing to the market growth. Furthermore, the growing prevalence of gene-related disorders is further anticipated to augment the market growth of preimplantation genetic testing. Additionally, growing awareness regarding genetic testing of a specific gene mutation among healthcare workers is again anticipated to foster market growth. Also, increasing maternal age and growing incidence of aneuploidy is expected to uplift the market growth in the near future.

From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high incidence of the gene-related disorder in the region. According to the U.S. Department of Health and Human Services, about 1 in 200,000 people in the United States are born with syndrome A each year. Around 1 in 100,000 people in the United States have syndrome A at the present time.

Key Developments:

In October 2019, PerkinElmer, Inc., a global provider of innovating for a healthier world, introduced it's PG-Seq™ Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit. This solution tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment.
In October 2018, Vitrolife AB (publ) has entered into a License and Commercialisation Agreement with Illumina, Inc., which provides Vitrolife with exclusive distribution, development, and commercialization rights to Illumina’s preimplantation genetic testing business for IVF in EMEA and Americas.
In July 2020, Chromosome Medicina Genômica, powered by GeneOne, enter into a partnership with Genomic Prediction and Diagnostics da America (DASA), to introduce LifeView™ PGT-P to Brazil.

Initiatives to Commercialize Specialized Reagents for Pyrogen Testing To Augment Growth of Pyrogen Testing Market

 Pyrogen testing determines the presence of endotoxin substances. Pharmaceutical and medical device industries are focused on R&D of more sustainable test methods for the accurate detection of pyrogenic contamination. Rabbit pyrogen test and the bacterial endotoxin test based on Limulus Amebocyte Lysate are some of the widely used pyrogen tests. Other tests include, recombinant factor C assay and monocyte activation assay.

Market Dynamics

Initiatives to commercialize specialized reagents for pyrogen testing are to propel growth of the pyrogen testing market over the forecast period. For instance, in May 2020, Lonza Sales AG partnered with Sanquin Reagents B.V. for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test (MAT).

Moreover, launch of new products is also expected to aid in growth of the market. For instance, in October 2020, Lonza Bioscience launched PyroCell MAT System, a sustainable and reliable solution for in vitro pyrogen testing. Similarly, in November 2019, Reading Scientific Services Ltd. launched a fast, responsive and flexible sterility testing service for pharmaceutical and medical device companies.

Increasing investment in the pharmaceutical sector is expected to offer lucrative growth opportunities for players in the pyrogen testing market. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million (est.) in 2018.

Moreover, stringent regulations regarding bacterial endotoxin testing for implants is also expected to aid in growth of the pyrogen testing market. For instance, in the U.S., the Food and Drug Administration (FDA)’s guidance document titled “Submission and Review of Sterility Information in Premarket Notification [510(k)] Submissions for Devices Labeled as Sterile” specifies new requirements related to bacterial endotoxin testing.

Growing concerns over use of animals in pyrogen testing is expected to hinder growth of the pyrogen testing market.

Competitive Analysis

Major players operating in the pyrogen testing market include, Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar

Major players in the pyrogen testing market are focused on adopting collaboration strategies to expand their product portfolio. For instance, in May 2018, Merck and Solvias announced collaboration plans to develop PyroMAT System, a new kit for detection of pyrogen.

Read More @ https://www.openpr.com/news/1861063/pyrogen-testing-market-strategic-insights-2019-2027-thermo

Emergence of Covid-19 to Offer Lucrative Growth Opportunities for Players in Protein A Resin Market

 Protein A colorimetric resins are the most extensively used affinity purifiers in bio-manufacturing and other industries. Protein A colorimetry is a robust, high-throughput chromatography method and is used primarily as a capture step because of its inherent precision.

Market Dynamics

Approval and launch of new biosimilars is expected to propel growth of the protein A resin market. For instance, in December 2020, Sandoz Canada Inc., a generics and biosimilars manufacturer and a division of the Switzerland-based multinational Novartis AG, received Health Canada authorization for Hyrimoz (adalimumab injection, reference biologic drug: Humira) on November 4, 2020 for marketing in Canada. Hyrimoz, the new biosimilar, has been approved for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, psoriasis and adult uveitis.

Moreover, high prevalence of chronic diseases is also expected to aid in growth of the protein A resin market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Increasing adoption of chromatography resins is expected to propel growth of the protein A resin market. For instance, in March 2020, Purolite Ltd. announced to supply its Praesto Jetted A50, an agarose-based Protein A chromatography resin, for use as part of the commercial manufacturing process of an FDA-approved monoclonal antibody treatment by a contract manufacturing organization. Similarly, in November 2020, Purolite Ltd. announced to supply its Protein A capture resin, Praesto Jetted A50 to WuXi Biologics, a global company with leading open-access biologics technology, for immediate use. WuXi Biologics.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the protein A resin market. For instance, in October 2020, Repligen Corporation and Navigo Proteins GmbH, a premier protein engineering company, announced their successful development of an affinity ligand targeting the spike protein, to be utilized in the purification of COVID-19 vaccines.

Competitive Analysis

Major players operating in the global protein A resin market include, GE Healthcare, Thermo Fisher Scientific, Repligen, Avantor, Inc., Purolite Ltd., Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd.

Major players operating in the global protein A resin market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2020, Avantor, Inc. launched a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.

Read more @ https://prnewsleader.com/tag/protein-a-resin-market-trend/

Disposable Gloves Market Is Expanding Rapidly as Industry Top Glove Introduces BioGreen Biodegradable Nitrile Gloves Meant for Disposal in Anaerobic Environment

 

Disposable gloves are gloves used for a variety of purposes including medical examinations and other industrial applications to prevent cross-contamination and protect the user’s hands. These gloves aren't made to be worn all the time, but rather, they're made to be discarded after use. Disposable gloves are extremely popular in the medical industry as they're perfect for all sorts of applications, including but not limited to suction applications, alcohol, and chemical applications.

Continuous research and development activities and new product launches are expected to drive growth of the global disposable gloves market during the forecast period. Key companies in the market are focused on research and development activities, in order to innovate a new product and gain a competitive advantage in the market. For instance, in July 2020, SW, a provider of hand health technologies, introduced a new Bantam brand of thermoplastic elastomer (TPE) gloves to cater to the demand for the shortage of gloves. Furthermore, in August 2020, Lath Nitrile Gloves launched Nitrile Rubber Gloves in the U.K. and U.S. markets. Many companies are focused on the continuous development of gloves that remove the potential transmission of bacteria and other pathogens that can be transmitted via gloves. Thus, these factors are expected to drive growth of the global disposable gloves market during the forecast period. Furthermore, increasing product demand in healthcare, pharmaceutical, chemical, oil & gas, and medical sectors is expected to boost the global disposable gloves market growth over the forecast period.

However, concerns regarding the use of natural rubber latex since they are allergic to some users combined with price fluctuation of rubber are expected to hinder the global disposable gloves market growth over the forecast period. Since healthcare infrastructure is expanding, it can provide significant growth opportunities to market players. Among regions, North America is expected to witness significant growth in the global disposable gloves market during the forecast period. This is owing to the presence of robust healthcare infrastructure and supportive government policies across the region. According to the U.S. Food and Drug Administration (FDA), gloves used for handling tools are certified under Title 21 Code of Federal Regulations Part 177. The components used in the manufacturing of gloves should comply with the FDA regulations. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to rising investments in the healthcare sector across the region. According to the India Brand Equity Foundation (IBEF), the Government of India is planning to increase public health expenditure to 2.5% of GDP by 2025.

Key players operating in the global disposable gloves market are Top Glove Corporation Bhd, Ansell Healthcare Products LLC, Supermax Corporation Berhad, Adventa Berhad, Shield Scientific B.V., Cardinal Health, Inc., Semperit AG Holding, Dynarex Corporation, Rubberex Corporation Bhd., Kossan Rubber Industries Bhd., MRK Healthcare Private Limited, and Hartalega Holdings Berhad.

For instance, in June 2019, Top Glove launched BioGreen Biodegradable Nitrile Gloves, a disposable glove that biodegrades in an anaerobic environment.

Read More @ https://www.openpr.com/news/2041896/disposable-gloves-market-2020-2026-develop-rapidly-by-top

Global Platelet Rich Plasma Market is Witness Massive Surge as U.S.-based Industry Leader Generex Biotechnology Corporation acquires Medisource Partners

 Platelet-rich plasma is a coagulated blood-rich polymer, made from extracted platelets. Extracted platelets are normally coagulated by monocytes or lymphocytes with fibrin. Platelets are also commonly injected into the body's bloodstream to support tissue healing following tissue surgery. Platelet-rich plasma has been found effective against bleeding disorders. It also helps reduce the risk of deep vein thrombosis (DVT) in patients with high blood pressure and in those taking anticoagulants. It may also reduce the risk of pulmonary embolism (PE), which is blood clots that enter the lungs and pulmonary system. In the chest, the clot can stop or limit the flow of blood to the heart. PE often leads to cardiac arrest and death.

Increasing cosmetic surgeries is expected to drive growth of the global platelet rich plasma market during the forecast period. Cosmetic surgeries refer to surgical specialty involving the restoration, alteration, or reconstruction of the human body. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2018, around 128,398 cosmetic procedures in Thailand and 1,036,618 procedures in Mexico were carried out. Hence, these factors are expected to drive growth of the global platelet rich plasma market during the forecast period. Furthermore, increasing prevalence of cosmetic surgeries is expected to boost the global platelet rich plasma market growth over the forecast period.

However, uncertainty regarding the efficiency of platelet-rich plasma products combined with the high cost of these products is expected to hinder the global platelet rich plasma market growth over the forecast period. Besides, continuous R&D activities in the field of plasma-rich bioactive molecules can present lucrative growth opportunities in the global platelet rich plasma market in the near future. Among regions, North America is expected to hold a dominant position in the global platelet rich plasma market during the forecast period. This is owing to increasing number of people suffering from orthopedic disorders. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to rising number of cosmetic surgeries facial features in emerging economies such as Thailand, India, and South Korea.

Key players operating in the global platelet rich plasma market are Estar Technologies Ltd., Arthrex, Inc., Generex Biotechnology Corporation, Stryker Corporation, Regen Lab S.A., Johnson and Johnsons Ltd., CollPlant, Zimmer Biomet Holdings Inc., Medira Ltd., Terumo Corporation, and Glofinn Oy.

For instance, in July 2019, Generex Biotechnology Corporation, a U.S.-based healthcare company, acquired Medisource Partners, a provider of medical and surgical products to process bone marrow aspirates and platelet rich plasma biologics.

High Prevalence of Primary Biliary Cholangitis and Approval and Launch of New Drugs to Augment Growth of Primary Biliary Cirrhosis Drugs Market

 

Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease of the liver. The auto-immune disorder can have a number of symptoms such as abdominal pain, fever, nausea, vomiting, abdominal bloating, diarrhea, liver tenderness or enlargement, jaundice, and ascites. In most of these symptoms, the patient may be experiencing inflammation at an early stage of the illness, although in some cases, symptoms do not appear until the disease has advanced to a more serious state. A definitive diagnosis can only be made by performing blood tests and ultrasound studies in order to determine the progression of the illness and its effects on the body. At an early stage, most patients who experience mild to moderate symptoms of primary biliary cholangitis exhibit no symptoms, whereas in some cases, symptoms manifest very quickly and rapidly worsen. In both conditions, the majority of affected individuals undergo treatment that is aimed at relieving pain and treating any complications that might occur.

Market Dynamics

High prevalence of primary biliary cholangitis is expected to propel growth of the primary biliary cirrhosis drugs market. For instance, according to the study, ‘Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis’, published in Hepatology International in September 2019, the overall prevalence of primary biliary cholangitis was 118.75 cases per million in the Asia Pacific region, with the high, medium and low prevalence being in Japan and China (191.18 cases per million), New Zealand (99.16 cases per million) and South Korea and Australia (39.09 cases per million), respectively.

Among regions, Europe is expected to witness significant growth in the primary biliary cirrhosis drugs market, owing to approval and launch of new products in the region. For instance, in December 2020, the European Commission, following the positive opinion from the Committee for Orphan Medicinal Products of the European Medicines Agency, granted orphan drug designation to Genkyotex’s lead drug candidate, setanaxib, for the treatment of primary biliary cholangitis.

Competitive Analysis

Major players operating in the primary biliary cirrhosis drugs market include, Intercept Pharmaceuticals, Inc., Johnson & Johnson, Zydus Cadila, GlaxoSmithKline Plc, Dr. Falk Pharma GmbH, Genkyotex, and Enanta Pharmaceuticals, Inc.

Major players operating in the primary biliary cirrhosis drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2020, the United States Food and Drug Administration granted "Fast Track Designation" to Zydus Cadila’s Saroglitazar Mg for the treatment of patients with primary biliary cholangitis.

Growing leisure spending around the globe is driving demand for Catamarans

 Catamarans are boats that were primarily used as a means of transport in the days before motor vessels. Catamarans, which were also called sailing catamarans, were first used by the Dutch in the seventeenth century as a means of traveling from island to island in a circular manner. In recent years, catamarans have gained increased popularity as a choice boat type. These days, people commonly choose catamarans for use as sailing boats or as water taxis - they are great for day cruises and provide comfort, luxury, and reliability.

The standard design of a catamaran is a triangular sail with one long side behind the other three. The Catamarans main function is as a means of transportation however, it does have some advantages that make it very popular among sailors. The most prominent advantage of using a catamaran passenger ferry is the fact that it is a lot lighter and more maneuverable than most other boats

Increasing disposable income coupled with the rapid growth in travel & tourism is projected to drive the market growth of Catamarans. According to the World Travel and Tourism Council (WTTC), in 2018, travel and tourism increased its share of leisure spending to 78.5 percent, up from 77.5 percent in 2017. Spending from international tourists also increased to 28.8 percent in 2018, up from 27.3 percent in 2017. Increasing focus on improving the boating structure coupled with the growing interest of people toward sailing, cruising, water sports, and campaigning is further anticipated to augment the market growth of the Catamarans.

North America is expected to gain significant growth over the forecast period and this is attributed to high leisure spending on boating activities. According to the U.S. Travel Association., direct spending on leisure travel by domestic and international travelers totaled $792.4 billion in 2019. International arrivals to the U.S. totaled approximately 79 million in 2019, about half of whom came from overseas.

Key Developments:

In February 2020, Aquila a provider of power catamarans has announced a significant factory expansion and plans to debut new models in 2020.
In September 2019, Volvo Penta's has launched a new electric Saildrive prototype at Cannes Yachting Festival. The electric prototype is based on Fountaine-Pajot's extensive customer usage database, which accurately defines drive cycles.
In October 2020, Maid of the Mist Corp. has launched new-generation Maid of the Mist vessels welded aluminum catamarans equipped with batteries that can produce 400-kilowatts. They power two 563-hp electric motors.

Read More @ https://www.openpr.com/news/1501568/catamarans-market-size-share-and-global-analysis-by-key-leaders-sunreef-yachts-spirited-designs-lagoon-catamaran-fountaine-pajot-matrix-yachts-voyage-yachts-tomcat-boats.html

MICRO-hospitals market is Gaining Major Traction with the launch of portable hospital for COVID-19 patients by an Indian startup Modulus Housing at IIT Madras University

 Micro-hospitals are hospitals designed both functionally and technically to provide the appropriate medical care in the most suitable place at the most affordable price. Health care services range from urgent medical assistance, acute surgical, elective surgery, long-term care, hospital care, home health care, extended care, specialty services, rehabilitation, social care, and community health care depending on market demand. Furthermore, these establishments offer specialty doctor opportunities for specialized services like cardiology, ear, nose, throat, and colostomy surgery; cardiopulmonary resuscitation (CPR), and intensive care medicine. The services offered by these facilities also cover rehabilitation services, skilled nursing facilities, and pediatric services. Healthcare facility design changes have played an important role in the way in which hospital facilities management addresses the issue of security. High tech emergency lights and emergency lighting has become a necessity in any modern hospital.

Low initial investment and better accessibility to healthcare facilities are expected to drive growth of the global micro-hospitals market during the forecast period. Micro-hospitals are gaining major traction due to the fact that it requires a low initial investment. These hospitals aim to bridge the gap between the ambulatory centers and free-standing emergency rooms as they are unable to provide adequate service. Besides, micro-hospitals require lesser time for construction as compared to large-scale hospitals. These hospitals primarily provide patient-centric care, convenience, and easier accessibility to healthcare facilities. Moreover, the number of patients in these hospitals are fairly low. Thus, these factors are expected to drive growth of the global micro-hospitals market during the forecast period. Moreover, declining admission rates of large-scale hospitals are expected to boost the global micro-hospitals market growth over the forecast period.

However, the lack of adequate and advanced facilities required for particular surgeries is expected to hinder the global micro-hospitals market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global micro-hospitals market during the forecast period. This is owing to per capita expenditure on healthcare across the region. According to the Centers for Disease Control and Prevention (CDC), around 90% of people in the U.S. have insurance coverage and are potential users of micro-hospitals.

Major competitors involved in the global micro-hospitals market are Emerus Hospitals, Christus Health, Baylor Scott & White Saint Luke’s Health System, Dignity Health, and SCL Health.

For instance, in August 2020, Modulus Housing, an Indian start-up incubated at a public technical and research university named IIT Madras, developed a portable hospital unit for COVID-19 patients.

Read more @ https://www.medgadget.com/2021/01/micro-hospitals-market-value-trend-2020-estimated-size-share-industry-segmentation-notable-growth-competitive-landscape-innovation-foreseen-by-2026.html

High demand for enzymes has played significant role in shaping up Bacillus Subtilis industry

 

Bacillus subtilis are gram-positive bacteria and is mostly found in the outer layer of the soil. It looks like a rod-shaped protective endospore and can withstand extremely harsh environmental conditions. It is widely used in the food &beverage industry for the processing of various food products. Industrial enzymes, agriculture, aquaculture, waste treatment, and pharmaceuticals are some of the other application areas of Bacillus subtilis. It is broadly classified into 100–300 billion CFU/g, <100 billion CFU/g, and > 300 billion CFU/g.
High demand for Bacillus subtilis from the biotechnology industry for the production of enzymes is driving the market growth. Moreover, growing demand for bacillus subtilis based pesticides as they are eco-friendly is again expected to foster market growth. Thus expanding the agriculture industry is projected to augment the market growth. Also, it is used in the preparation of various food products which is again propelling the market growth. The increasing population coupled with the growing demand from aquatic animal feeding and feed application is further projected to propel the market growth of the Bacillus subtilis over the forecast period. Additionally, growing demand for non-toxical bacterial products coupled with the shifting consumer preferences will favor the market growth over the forecast timeframe.
Besides, penetration of various key manufacturer in the market is projected to open new doors of opportunities in the near future.
From the geographical point of view, North America is projected to exhibit significant growth over the forecast period and this is attributed to increasing spending on the food industry. According to the Economic Research Service United States Department of Agriculture, in 2019, U.S. consumers, businesses, and government entities spent $1.77 trillion on food and beverages in grocery stores and other retailers and on away-from-home meals and snacks. Also, the strong presence of the biotechnology industry in the region is further ant
Key Developments:
1. In August 2020, Brazilian company Biotrop announced a new biological nematicide called Furatrop that combines Japanese Hayai technology and the CNPSo2657 strain of Bacillus subtilis, and reduces damage to soybean and several other crops.
2. In July 2020, Cambridge Commodities announced the launch of our new ActiBio® probiotic solution containing Bacillus subtilis, ActiBio®-BS (P13511).
3. In October 2018, Bayer’s launched Serenade™ ASO fungicide/bactericide. It is a powerful biological crop protection product designed to protect against the effects of soil and foliar bacterial and fungal diseases.

Read more @ https://www.openpr.com/news/2011994/bacillus-subtilis-market-2020-growth-drivers-trends

Emergence of Covid-19 to Offer Lucrative Growth Opportunities for Players in Intelligent Virtual Assistant Market

 

An Intelligent Virtual Assistant is a computer program that mimics human interaction in order to carry out specific tasks, such as client service. Intelligent Virtual Assistants are now used for various applications across several industries. In business, they may be employed by call centers and BPO firms to assist their clients in completing tasks that may be tiresome or time-consuming for them. They also provide services like data entry, typing, speech transcription, answering phone calls, email and transcription. In the education sector, Virtual Assistants provide tuition management services and bookkeeping among others.

There are two main technologies that make up this type of a Virtual Assistant: the visual, artificial intelligence (or VAI) and the verbal artificial intelligence (VAA). The Virtual Assistant programs are able to detect key information in conversations, and then communicate this information through appropriate user interfaces. This enables a Virtual Assistant to understand, process, and reply to customer queries in a natural manner. Because of this, most Virtual Assistants operate on a "self-service" basis whereby they can suggest or even direct the customer in certain ways to make certain tasks easier. In addition, the software also provides the client with an interface that allows them to control their VA via chat or telephone.

Market Dynamics

Increasing generation of data is expected to propel growth of the intelligent virtual assistant market. For instance, according to International Data Corp, the total volume of data is expected to reach 175 zettabytes in 2025, of which around 80% is expected to be unstructured data.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the intelligent virtual assistant market. Various sectors have begun adopting intelligent virtual assistant to avoid human interaction and to contain the spread of the novel coronavirus.

Factors such as high cost and complexity associated with virtual assistant along with lack of skilled personnel are expected to restrain growth of the global intelligent virtual assistant market.

Major players operating in the global intelligent virtual assistant market include, NextIT Corp., eGain Communications Corp., Creative Virtual Ltd., Conversica, Inc., Artificial Solutions Ltd., Creative Virtual Ltd., SpeakToit Inc., Anboto Group., IntelliResponse Systems Inc., Nuance Communications Inc., Five9 Inc., and CodeBaby Corp.

December 2020: Conversica, Inc. announced a reseller agreement with Affinitiv, a leading provider of data-driven marketing and software solutions to the automotive market. Through this agreement, Affinitiv is tightly integrating Conversica Intelligent Virtual Assistants with Affinitiv’s XRM platform, giving dealerships a highly reliable and seamless exchange of data to accelerate retailer performance and enhance the vehicle shopper’s experience.

Read more @ https://prnewsleader.com/uncategorized/346714/intelligent-virtual-assistant-market-2020-with-covid-19-impact-analysis-covering-top-keyholders/

Increasing Prevalence of Orthopedic Disorders to Augment the Orthopedic Power Tools Market Growth

 

Orthopedics is a branch of medicine that focuses on the diagnosis, improvement, prevention, and treatment of patients with musculoskeletal deformities such as skin ligaments, tendons, nerves, joints, and bones disorders. Orthopedic power tools are lighter, user-friendly than conventional orthopedic tools and can be easily handled while performing orthopedic surgeries. These tools are classified into three types such as pneumatic power tools, battery-operated power systems, and electric powered orthopedic tools. However, the orthopedic power tools have revolutionized the world of orthopedic surgery. These tools help healthcare to perform surgical procedures with greater pace, more precision, and higher accuracy.

The increasing demand for minimally invasive surgeries worldwide to treat various disorders (such as spinal, neurosurgical, and orthopedic diseases), growing population, rising number of accidents, and increasing incidence of spinal injuries is driving the orthopedic power tools market growth. According to the National Spinal Cord Injury Statistical Center, each year, around 17,700 new cases of spinal cord injury are diagnosed in the United States. In 2018, around 54 people in the U.S. (per one million) suffered from spinal cord injury. Orthopedic power tools are used to perform minimally invasive surgeries with a minuscule incision, reduce the risk of bleeding, shorten hospital stay, and offer faster recovery.

Increasing prevalence of orthopedic disorders, increasing demand for orthopedic procedures (to treat conditions such as fractures, osteoporosis, osteoarthritis, etc.), and technological advancements are some of the major factors attributing to the growth of the orthopedic power tools market. According to the Centers for Disease Control and Prevention, osteoarthritis is the most common type of joint disease, affecting more than 30.5 million individuals in the U.S. alone. Moreover, the risk of developing osteoarthritis increases with age, while women are more likely to develop osteoarthritis than men, especially after age 50.

In terms of geography, the orthopedic power tools market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. North America is expected to witness substantial growth in the market due to the presence of key players in the region. Key players are focused on product approvals and product launches to strengthen their market presence. For instance, in January 2019, Medtronic announced the commercial launch of an orthopedic power tool, Mazor X stealth edition, for robotic-assisted spine surgeries. However, the high cost of orthopedic procedures is expected to hamper the orthopedic power tools market growth.

Read more @ https://www.businesswire.com/news/home/20201104005330/en/Global-Orthopedic-Power-Tools-Market-to-Surpass-US-1200.8-Million-by-2027-Says-Coherent-Market-Insights-CMI

Potential Use of Kefir as an Inhibitor of Expression of Proinflammatory Cytokines in Covid-19 Patients to Augment Growth of Kefir Market

 kefir, is a fermented milk drink similar to a thin yogurt that is made from kefir grains. It is a thick curd like dairy product that looks like cottage cheese. Some varieties of Kefir are also made with rice instead of yogurt. Whatever the case, these products are rich in probiotics like acidophilus and healthy bacteria.

Kefir can come in many forms and are often used in different cuisines. Kefir milk can be used plain, as a top for cereal salads, smoothies, or other applications. It can also be used as a good substitute for buttermilk or sour cream in baking recipes. Water Kefir can be easily made with water or with only water to remove some of the whey, creating a very thick, high quality kefir from fermented water. This is a great option to try if you are a low calorie diet, as kefir will cut the calories you take in when using it as a milk replacement.

Market Dynamics

Increasing production of milk is expected to propel growth of the global kefir market. For instance, the USDA National Agricultural Statistics Service (NASS) estimated November 2019 U.S. milk production at 17.440 billion pounds, 0.5 percent higher than November 2018. Moreover, launch of kefir products is also expected to aid in growth of the market. For instance, in November 2020, Biotiful Dairy launched new kefir yogurt range in the U.K.

Potential of kefir as a Protective dietary supplementation against viral infection is expected to offer lucrative growth opportunities for players in the global kefir market. For instance, in November 2020, researchers from Molecular Biology Unit, Department of Zoology, Faculty of Science, Alexandria University, Egypt and Saud University, Riyadh, Saudi Arabia, reported that Kefir and kefir derivatives can suppress viral activity by modulating immune-system responses and/or causing disruption of viral adhesion. Moreover, the study highlighted the potential use of kefir (and its byproducts) as an inhibitor of expression of proinflammatory cytokines in COVID-19 patients.

However, increasing preference for vegan food is expected to hinder growth of the global kefir market. For instance, according to The Vegan Society, the number of people consuming only vegetarian food in the U.K. increased from 276,000 in 2016 to 600,000 in 2019.

Completive Analysis

Major players operating in the global kefir market include, Groupe Danone, Lifeway Foods Inc., Nourish Kefir, Fresh Made Inc., Babushka Kefir, Valio Eesti A.S., Litehouse Foods, and Hain Celestial Group.

September 2019: Lifeway Foods, Inc. demonstrated several new offerings and bestselling favorites including New Kefir Minis and Plantiful Kids Line at the Natural Products Expo East 2019 in Baltimore, Maryland.

Read More @ https://www.openpr.com/news/2050138/kefir-market-volume-analysis-size-share-and-key-trends

Global Video Telemedicine Market is Witnessing Significant Growth as industry leader VSee lab Inc. partners with Vuzix Corporation to introduce an innovative telemedicine product

 Video telemedicine uses technology primarily computers, video, messaging, and phone by medical professionals to diagnose and treat patients in remote locations. Video telemedicine or telemedicine involves the use of electronic communications and software for management of chronic conditions.

Increasing prevalence of hospital-acquired infection and increasing incidences of white coat syndrome is expected to drive growth of the global video telemedicine market during the forecast period. According to the Indian Journal Medical Research (IJMR), in 2017, surgical-site infections (SSIs) were the most common HAI with prevalence of 23.94% followed by hospital-acquired pneumonia with 18.31%, catheter-related blood stream infection (16.9%), and urinary tract infections (16.9%) in India. Such high prevalence has led to increase in demand for video telemedicine globally. Video telemedicine offers numerous advantages such as less time in waiting room, no transportation time and cost, and fewer chances of catching a new illness. Thus, these factors are expected to drive growth of the global video telemedicine market during the forecast period. Moreover, growing geriatric population is expected to boost the global video telemedicine market growth over the forecast period. According to the World Health Organization (WHO), by 2050, global population of aged 60 years and above is expected to reach 2 billion, increasing from 900 million in 2015. Video telemedicine is a perfect alternative to geriatric people to get medical treatments and medications without actually visiting the doctor’s office.

However, lack of skilled personnel and adequate infrastructure is expected to restrain growth of the global video telemedicine market during the forecast period. Besides, lack of awareness regarding the technology in emerging economies is expected to hinder the global video telemedicine market growth in the near future. Among regions, North America is expected to witness significant growth in the global video telemedicine market during the forecast period. This is owing to wide implementation of video telemedicine and increasing demand for unnecessary transpiration. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing patient pool and healthcare practitioners in the region.

Key companies operating in the global video telemedicine market are Life-Size Communication Inc., Vidyo Inc., Vermont Tel, Sony Corporation, Huawei Technologies Co Ltd., GlobalMed Inc., Premiere Global Services Inc., and VSee lab Inc.

For instance, in November 2020, Vuzix Corporation partnered with VSee lab Inc., a U.S.-based telehealth company to introduce a telehealth and telemedicine smart glasses solution Vuzix Blade Smart Glasses and Vuzix' M300XL.

Read More @ https://www.openpr.com/news/2213244/video-telemedicine-market-analysis-over-numerous-prominent

High Consumption of Alcohol to Augment Growth of the Global Distilled Spirits Market

 Distilled spirits, also known as "distilled liquor," are simply alcohol that has been distilled. Distilled alcohol is a legal term in most states and countries. In the United States, distilled spirit is defined as the product produced by removing any material that influences the taste, aroma, or color of the final product. This can include anything from wood chips to chemicals used during distillation. Distilled liquor is generally separated into three categories: Gin, Blintz, and Whiskey. Distilled gin is made by washing gin and vermouth in distilled water and then storing it in new bottles.

Distilled Vodka, Distilled Gin, Distilled Rum, Distilled Tequila, and Distilled Brandy are some of the many Distilled Spirit products available. A distilled spirit, or vodka, is basically an alcohol that has been distilled instead of fermented like wine and beer. Distilled alcohols include brandy, rum, gin, whiskey, tequila, and sparkling wine, among many others. Distilled liqueurs include gin, sparkling wine, brandy, triple sec, amaretto, sodas lite, tonic waters, lique, and many more. Botanicals, which come from plant life, are added to Distilled Gin to add flavor and depth to the drink. For Distilled Rum, cane, nutmeg, and other spices are added to the marjoram and the sugarcane are added for a sweet, tropical flavor.

Market Dynamics

High consumption of alcohol is expected to propel growth of the global distilled spirits market. For instance, according to the 2018 National Survey on Drug Use and Health (NSDUH), 86.3 percent of people ages 18 or older reported that they drank alcohol at some point in their lifetime.

Increasing disposable income is expected to offer lucrative growth opportunities for players in the global distilled spirits market. For instance, according to Organization for Economic Co-operation and Development (OECD) the disposable income of Africa increased by an annual growth rate of 1.5% during 2015-2018.

Stringent government regulations such as ban on advertisement of alcoholic beverages in public places and limited, permissible consumption of these products is expected to hinder growth of the distilled spirits market.

Among regions, Asia Pacific is expected to witness significant growth in the global distilled spirits market, owing to increasing disposable income in the region. For instance, according to the National Bureau of Statistics (China), the urban and rural per capita disposable income in China reached US$ 5,600 and US$ 2,000 in 2018, an increase of 5.6% and 6.6% in real terms after deducting price factors, respectively.

Competitive Analysis

Major players operating in the global distilled spirits market include, Diageo plc, Pernod-Ricard SA, Constellation Brands Inc., Brown-Forman Corporation, Remy Cointreau SA, Marie Brizard Wine & Spirits, Lapostolle SA and Berentzen-Gruppe AG.

October 2020: Diageo plc signed an agreement to acquire Chase Distillery, the owner of Chase GB Gin and Chase Original Potato Vodka.

Read More @ https://www.openpr.com/news/2096681/distilled-spirits-market-aming-to-capture-largest-market-share

EMI Shielding Materials Market is Rapidly Growing as Key Industry Leader PPG Industries Comes up with PPG TESLIN EMI/RF shielding material to protect electronic security documents

 

EMI Shielding is the scientific term for electro-mechanical interconnection failures and EMI coupling. A good EMI Shielding Material is one that reduces or nullifies the adverse effects of electromagnetic interferences upon systems. EMI and RFI are known as harmful radio frequency interferences which are emitted from many electronic devices. These harmful emissions form a byproduct of operation. EMI and RFI are said to occur when devices are exposed to electrical fields in their primary active circuit areas which generate electric pulses. This shield is also utilized to protect and prevent human beings from the harmful emissions created by power tools, vibrators, industrial ovens, air conditioners, microwave ovens, and stoves, etc. Apart from these power tools, other electrical gadgets include microwave ovens, stoves, dishwashers, refrigerators, etc.

Rising demand for consumer electronics is expected to drive growth of the global EMI shielding materials market during the forecast period. The demand for consumer electronics such as smartphones, laptops, smart TVs, tablets, and more has increased significantly over the years in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), in 2019, the Indian appliance and consumer electronics (ACE) market was valued at US$ 10.93 billion and is expected to reach US$ 21.18 billion by 2025. Consumer electronic devices require enhanced radiation shielding since these devices are using better circuits and chips. Hence, these factors are expected to drive growth of the global EMI shielding materials market during the forecast period. Furthermore, rising electromagnetic pollution and strict environmental regulations in various industries are expected to propel the global EMI shielding materials market growth over the forecast period.

However, high cost of EMI shielding is expected to hamper the global EMI shielding materials market growth over the forecast period. Besides, increasing the adoption of advanced technologies in modern automobiles can present lucrative growth opportunities for market players in the near future. Among regions, Asia Pacific is expected to witness significant growth in the global EMI shielding materials market during the forecast period. This is owing to the presence of a large hub for manufacturing electronic equipment in emerging economies such as China, South Korea, Japan, and India. Furthermore, North America is expected to register a robust growth rate over the forecast period, owing to the presence of a robust telecommunication sector in the region.

Major companies involved in the global EMI shielding materials market are 3M Company, Orion Industries, AI Technology, EMI Shielding Materials Company, Greene Rubber Company, Omega Shielding Products, Schaffner Holding, Cybershield Inc., PPG Industries, CGC Precision Technology, and ETS- Lindgren.

For instance, in November 2020, PPG Industries, a U.S.-based supplier of coatings and specialty materials, introduced PPG TESLIN EMI/RF shielding material that offers improved RF-shielding performance for electronic passports and electronic security documents.

Read More @ https://prnewsleader.com/news/1331610/new-market-study-of-emi-shielding-materials-market-and-its-detail-analysis-by-regions-and-focusing-on-key-players/

Biodegradable Loose Fill Packaging Is the Best Packaging Solution That Protects Products from Damage during Transportation

 

The root of packaging lies in the protection of products, equipment, and machinery from external damage during its storage and shipping. Many packaging options are available in the market that provides appealing values to products from various industries. Of which, loose fill packaging is the best packaging solution that provides protection to products during shipment between manufacturers, retailers, distributors, and consumers. Loose fill materials are used to fill the empty spaces in the box and protect products from damage during transportation. Many types of biodegradable loose fill packaging materials are available in the market.
Biodegradable loose fill packaging is increasingly growing in popularity worldwide due to growing awareness of environmental concerns such as increased pollution caused by plastic waste. Manufacturing of loose fill does not require chemical agents, thus avoid issues linked to harmful gas emissions. Such advantages of loose fill materials are one of the major driving factors for the growth of the biodegradable loose fill packaging market. Moreover, the growth of the packaging industry is also expected to drive the market growth. The packaging industry in India is expected to reach US$ 30 to 35 billion by 2020, growing at an annual rate of 15%.
Based on application, the biodegradable loose fill packaging market is divided into cosmetics and personal care products packaging, pharmaceutical packaging, consumer goods packaging, etc. Consumer goods packaging segment dominated the market in 2017 and is expected to maintain its dominance due to increasing sales of consumer goods. According to Statista, global retail sales of consumer goods are expected to reach US$ 26.7 trillion by 2022. Moreover, the increasing number of smartphones and internet usage is increasing the growth of e-retail sales, leading to market growth. According to Datareportal, there are around 4.66 billion internet users in the world and the number grew by 321 million in the past 12 months.
Shifting consumer preference from offline to online retail is expected to increase demand for protective packaging, leading to market growth. In terms of geography, the biodegradable loose fill packaging market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Key players active in the market are adopting various strategies such as product development, business collaboration, and Mergers & acquisitions to strengthen their product portfolio. For instance, in June 2018, Pregis signed an agreement to purchase Free-Flow Packaging International.

Read More @ https://www.openpr.com/news/2026241/covid-19-analysis-analysis-biodegradable-packaging-market

Single-use Medical Device Reprocessing is Witnessing Massive Boom with the Outbreak of COVID-19 Pandemic

 

Single-use medical device reprocessing refers to cleaning, disinfection, testing, sterilization, and remanufacturing of a used medical device to be put in service again. The reuse of single-use medical devices first began in the late 1970s. According to the Centers for Disease Control and Prevention (CDC), around 20 to 30% of the U.S. hospitals reported having reused at least one type of single-use device. The reuse of single-use devices involves ethical, regulatory, legal, medical, and economic issues, which have faced controversy in the last two decades. The reuse of single-use medical devices has increased typically due to the COVID-19 pandemic outbreak.

In general, there are two categories of products that can be reused: active and inert. Active products are required for making new products, while inert products are used for making old products stronger, newer, longer-lasting, and more effective. The useful products that are generated are called inert products. These are products that have a certain amount of value because of their function. They are available in different forms like paper, paperboard, metals, plastic, etc. These products can either be reclaimed from the environment, or produced by industries and used for manufacturing purposes. The mobile devices that need to be recycled for single-use medical device reprocessing include diagnostic devices, sterilization equipment, biopsy instruments, blood glucose analyzers, blood pressure monitors, disposable gloves, medical imaging devices, and many more.

These are the most important and widely used devices. There are so many reasons behind the use of such mobile medical equipment. It is important to note that reused single-use devices will have to comply with the same regulatory requirements when it was originally manufactured. Furthermore, every country has its unique regulatory guidelines regarding single-use medical device reprocessing. For instance, in the U.S., the Food and Drug Administration (FDA) releases guidelines on how single-use medical devices should be reused and how they should be reprocessed. Many companies in the Drug Administration U.S., Italy, and Singapore are focused on introducing novel procedures to reuse single-use medical devices.

Read More @ https://prnewsleader.com/uncategorized/2074712/single-use-medical-device-reprocessing-market-size-share-application-analysis-regional-outlook-competitive-strategies-and-forecast-2020-2027/